Skip to main content
. 2013 May 10;18(5):619–624. doi: 10.1634/theoncologist.2012-0465

Table 1.

Summary of approved indications

graphic file with name onc00513-1340-t01.jpg

Abbreviations: AML, acute myeloid leukemia; CMML, chronic myelomonocytic leukemia; EMA, European Medicines Agency; FAB, French-American-British; FDA, U.S. Food and Drug Administration; IPSS, International Prognostic Scoring System; MDS, myelodysplastic syndrome.